Virtual screen to NMR (VS2NMR): Discovery of fragment hits for the CBP bromodomain

被引:17
作者
Spiliotopoulos, Dimitrios [1 ]
Zhu, Jian [1 ]
Wamhoff, Eike-Christian [2 ,3 ]
Deerain, Nicholas [1 ]
Marchand, Jean-Remy [1 ]
Aretz, Jonas [2 ,3 ]
Rademacher, Christoph [2 ,3 ]
Caflisch, Amedeo [1 ]
机构
[1] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland
[2] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Muhlenberg 1, D-14424 Potsdam, Germany
[3] Free Univ Berlin, Dept Biol Chem & Pharm, Inst Med & Biochem, Takustr 3, D-14195 Berlin, Germany
基金
瑞士国家科学基金会;
关键词
Docking; Virtual screening; NMR spectroscopy; Epigenetics; X-ray crystallography; Bromodomain inhibitors; BINDING; INHIBITORS; LIGANDS; DOCKING; POTENT; BRD4; IDENTIFICATION; OPTIMIZATION; DESIGN;
D O I
10.1016/j.bmcl.2017.04.001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Overexpression of the CREB-binding protein (CBP), a bromodomain-containing transcription coactivator involved in a variety of cellular processes, has been observed in several types of cancer with a correlation to aggressiveness. We have screened a library of nearly 1500 fragments by high-throughput docking into the CBP bromodomain followed by binding energy evaluation using a force field with electrostatic solvation. Twenty of the 39 fragments selected by virtual screening are positive in one or more ligand-observed nuclear magnetic resonance (NMR) experiments. Four crystal structures of the CBP bromodomain in complex with in silico screening hits validate the pose predicted by docking. Thus, the success ratio of the high-throughput docking procedure is 50% or 10% if one considers the validation by ligand-observed NMR spectroscopy or X-ray crystallography, respectively. Compounds 1 and 3 show favorable ligand efficiency in two different in vitro binding assays. The structure of the CBP bromodomain in the complex with the brominated pyrrole 1 suggests fragment growing by Suzuki coupling. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2472 / 2478
页数:7
相关论文
共 50 条
[31]   Discovery of Highly Potent Microsomal Prostaglandin E2 Synthase 1 Inhibitors Using the Active Conformation Structural Model and Virtual Screen [J].
He, Shan ;
Li, Cong ;
Liu, Ying ;
Lai, Luhua .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (08) :3296-3309
[32]   Fragment Screening and Druggability Assessment for the CBP/p300 KIX Domain through Protein-Observed 19F NMR Spectroscopy [J].
Gee, Clifford T. ;
Koleski, Edward J. ;
Pomerantz, William C. K. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (12) :3735-3739
[33]   Fragment-Based Ligand Discovery Using Protein-Observed 19F NMR: A Second Semester Organic Chemistry CURE Project [J].
Bur, Scott K. ;
Pomerantz, William C. K. ;
Bade, Morgan L. ;
Gee, Clifford T. .
JOURNAL OF CHEMICAL EDUCATION, 2021, 98 (06) :1963-1973
[34]   Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV-CA Binding Fragments [J].
Lang, Stuart ;
Fletcher, Daniel A. ;
Petit, Alain-Pierre ;
Luise, Nicola ;
Fyfe, Paul ;
Zuccotto, Fabio ;
Porter, David ;
Hope, Anthony ;
Bellany, Fiona ;
Kerr, Catrina ;
Mackenzie, Claire J. ;
Wyatt, Paul G. ;
Gray, David W. .
CHEMMEDCHEM, 2024, 19 (13)
[35]   An NMR Biochemical Assay for Fragment-Based Drug Discovery: Evaluation of an Inhibitor Activity on Spermidine Synthase of Trypanosoma cruzi [J].
Yamasaki, Kazuhiko ;
Tani, Osamu ;
Tateishi, Yukihiro ;
Tanabe, Eiki ;
Namatame, Ichiji ;
Niimi, Tatsuya ;
Furukawa, Koji ;
Sakashita, Hitoshi .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) :2261-2266
[36]   CcpNmr AnalysisScreen, a new software programme with dedicated automated analysis tools for fragment-based drug discovery by NMR [J].
Mureddu, Luca G. ;
Ragan, Timothy J. ;
Brooksbank, Edward J. ;
Vuister, Geerten W. .
JOURNAL OF BIOMOLECULAR NMR, 2020, 74 (10-11) :565-577
[37]   A combined fragment-based virtual screening and STD-NMR approach for the identification of E-cadherin ligands [J].
Vasile, Francesca ;
Lavore, Francesca ;
Gazzola, Silvia ;
Vettraino, Chiara ;
Parisini, Emilio ;
Piarulli, Umberto ;
Belvisi, Laura ;
Civera, Monica .
FRONTIERS IN CHEMISTRY, 2022, 10
[38]   Discovery of Tyk2 inhibitors via the virtual site-directed fragment-based drug design [J].
Jang, Woo Dae ;
Kim, Jun-Tae ;
Son, Hoon Young ;
Park, Seung Yeon ;
Cho, Young Sik ;
Koo, Tae-Sung ;
Lee, Hyuk ;
Kang, Nam Sook .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (18) :3947-3952
[39]   19F NMR viewed through two different lenses: ligand-observed and protein-observed 19F NMR applications for fragment-based drug discovery [J].
Buchholz, Caroline R. ;
Pomerantz, William C. K. .
RSC CHEMICAL BIOLOGY, 2021, 2 (05) :1312-1330
[40]   A more detailed picture of the interactions between virtual screening-derived hits and the DNA G-quadruplex: NMR, molecular modelling and ITC studies [J].
Trotta, Roberta ;
De Tito, Stefano ;
Lauri, Ilaria ;
La Pietra, Valeria ;
Marinelli, Luciana ;
Cosconati, Sandro ;
Martino, Luigi ;
Conte, Maria R. ;
Mayol, Luciano ;
Novellino, Ettore ;
Randazzo, Antonio .
BIOCHIMIE, 2011, 93 (08) :1280-1287